Prolonged remissions after anti-PD1 discontinuation in patients with Hodgkin lymphoma

Guillaume Manson (1) , Charles Herbaux (2) , Pauline Brice (3) , Krimo Bouabdallah (4) , Aspasia Stamatoullas , Jean-Marc Schiano (5) , Hervé Ghesquieres (6) , Laurent Dercle (7, 8) , Roch Houot (9)

1 Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Ponchaillou]
2 CHRU Lille - Centre Hospitalier Régional Universitaire [CHU Lille]
3 AP-HP - Assistance publique - Hôpitaux de Paris (AP-HP)
4 CHU Bordeaux
5 IPC - Institut Paoli-Calmettes
6 CHLS - Centre Hospitalier Lyon Sud [CHU - HCL]
7 UMR 1015 - Immunologie des tumeurs et immunothérapie
8 Médecine nucléaire
9 MICMAC - Microenvironment, Cell Differentiation, Immunology and Cancer

Domaines: Cancer

Guillaume Manson, Charles Herbaux, Pauline Brice, Krimo Bouabdallah, Aspasia Stamatoullas, et al.. Prolonged remissions after anti-PD1 discontinuation in patients with Hodgkin lymphoma. Blood, 2018, 131 (25), pp.2856-2859. ⟨10.1182/blood-2018-03-841262⟩. ⟨hal-01812478⟩